Total planned funding: $171,269,138
Allocations
Countries/Regions
| India | $171,269,138 |
Organizational Types
| Unknown | $73,225,561 |
| NGO | $48,707,705 |
| Own Agency | $30,946,383 |
| University | $8,740,217 |
| Multi-lateral Agency | $3,760,000 |
| FBO | $2,700,000 |
| Private Contractor | $2,589,272 |
| Host Country Government Agency | $600,000 |
Program Areas
| Governance and Systems | $59,590,282 |
| Prevention | $45,050,780 |
| Care | $24,493,363 |
| Management and Operations | $22,282,701 |
| Testing | $10,196,534 |
| Treatment | $9,655,478 |
Budget Codes
| OHSS: Health Systems Strengthening | $29,546,160 |
| HVMS: Management and Operations | $22,282,701 |
| HVSI: Strategic Information | $22,096,913 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $22,089,728 |
| HBHC: Care: Adult Care and Support | $15,689,089 |
| HVCT: Testing: HIV Testing and Counseling | $10,196,534 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,755,693 |
| HTXS: Treatment: Adult Treatment | $8,948,853 |
| HLAB: Laboratory Infrastructure | $7,947,209 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,112,021 |
| HVTB: Care: TB/HIV | $4,468,917 |
| HKID: Care: Orphans and Vulnerable Children | $3,740,578 |
| HMBL: Biomedical Prevention: Blood Safety | $3,603,274 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,490,064 |
| PDTX: Treatment: Pediatric Treatment | $683,148 |
| PDCS: Care: Pediatric Care and Support | $594,779 |
| HTXD: Treatment: ARV Drugs | $23,477 |
Top Partner Programs
Not Available:
$73,225,561
Countries/Regions
USG Aggregated Agencies:
$22,379,069
Countries/Regions
FHI 360:
$18,748,882
Countries/Regions
Voluntary Health Services:
$8,060,000
Countries/Regions